Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Venous Thrombosis

  Free Subscription


Articles published in Thromb Res

Retrieve available abstracts of 332 articles:
HTML format



Single Articles


    August 2022
  1. GORAN K
    Search for obtaining the highest net clinical benefit in pulmonary embolism patients: A new improvement considering the safety of thrombolysis.
    Thromb Res. 2022;218:5-7.
    PubMed    


  2. WANG WD, Wei JP, Gao RQ, Yang QC, et al
    A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers.
    Thromb Res. 2022;216:52-58.
    PubMed     Abstract available


  3. WIEGERS HMG, Scheres LJJ, Tahir L, Hutten BA, et al
    Risk of venous thromboembolism in women with endometriosis.
    Thromb Res. 2022;217:104-106.
    PubMed    


    July 2022
  4. ATA F, Ibrahim WH, Choudry H, Shams A, et al
    Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2022;217:86-95.
    PubMed     Abstract available


  5. CHOI SH, Nguyen H, Kanjwal S, Ibrahim I, et al
    COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data.
    Thromb Res. 2022;217:60-63.
    PubMed    


  6. MAHARAJ S, Chang S, Kloecker G, Chesney J, et al
    Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.
    Thromb Res. 2022;217:48-51.
    PubMed    


  7. ZUIN M, Rigatelli G, Bilato C, Bongarzoni A, et al
    Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry.
    Thromb Res. 2022;217:15-21.
    PubMed    


  8. PANCANI R, Villari L, Aquilini F, Palla A, et al
    Prognostic role of respiratory failure in acute pulmonary embolism: a prospective multicenter study.
    Thromb Res. 2022;217:33-35.
    PubMed    


  9. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
    Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
    Thromb Res. 2022;216:113-119.
    PubMed     Abstract available


    June 2022
  10. FANG MC, Go AS, Prasad PA, Zhou HX, et al
    Health-related quali ty of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
    Thromb Res. 2022;216:97-102.
    PubMed     Abstract available


  11. SHIBAHASHI E, Jujo K, Kuroda S, Matsumoto S, et al
    Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.
    Thromb Res. 2022;216:90-96.
    PubMed     Abstract available


  12. VEETTIL SK, Harris J, Syeed MS, Thakkinstian A, et al
    Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
    Thromb Res. 2022;216:74-83.
    PubMed     Abstract available


  13. SHEN J, Casie Chetty S, Shokouhi S, Maharjan J, et al
    Massive external validation of a machine learning algorithm to predict pulmonary embolism in hospitalized patients.
    Thromb Res. 2022;216:14-21.
    PubMed     Abstract available


  14. GUMAN NAM, van Haaps TF, van Es N, Leeflang MMG, et al
    Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism.
    Thromb Res. 2022;216:11-13.
    PubMed    


    May 2022
  15. BRANDT W, Brown C, Wang TF, Tagalakis V, et al
    Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
    Thromb Res. 2022;216:8-10.
    PubMed     Abstract available


  16. SUBHANI M, Sheth A, Ahmed J, Wijayasiri P, et al
    Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
    Thromb Res. 2022;215:19-29.
    PubMed     Abstract available


  17. OBRADOVIC S, Subotic B, Dzudovic B, Matijasevic J, et al
    Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy.
    Thromb Res. 2022;214:138-143.
    PubMed     Abstract available


  18. BIKDELI B, Piazza G, Jimenez D, Muriel A, et al
    Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
    Thromb Res. 2022;214:122-131.
    PubMed     Abstract available


  19. ROSA V, Chaar CIO, Espitia O, Otalora S, et al
    A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome.
    Thromb Res. 2022;213:65-70.
    PubMed     Abstract available


  20. BARBERO E, Manas E, Bikdeli B, Garcia-Ortega A, et al
    Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2022;214:87-92.
    PubMed     Abstract available


  21. MONREAL M, Bertoletti L, Lopez-Nunez JJ, Tiberio G, et al
    TEMPORARY REMOVAL: OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study.
    Thromb Res. 2022;213 Suppl 2:S8-S9.
    PubMed     Abstract available


  22. BOSCH FTM, Campello E, Henderson MW, Mulder FI, et al
    TEMPORARY REMOVAL: OC-07: Contact pathway activation and risk of venous thromboembolism in patients with pancreatic cancer: the prospective SENECA study.
    Thromb Res. 2022;213 Suppl 2:S4.
    PubMed     Abstract available


  23. OVERVAD TF, Ording AG, Nielsen PB, Piazza G, et al
    TEMPORARY REMOVAL: OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors.
    Thromb Res. 2022;213 Suppl 2:S4-S5.
    PubMed     Abstract available


  24. ANTONUCCI E, Barcella L, Russo L, Chistolini A, et al
    TEMPORARY REMOVAL: PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry.
    Thromb Res. 2022;213 Suppl 2:S39.
    PubMed     Abstract available


  25. MARTIN AM, Lecumberri R, Souto JC, Aparicio J, et al
    TEMPORARY REMOVAL: PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients.
    Thromb Res. 2022;213 Suppl 2:S38-S39.
    PubMed     Abstract available


  26. LOPEZ-NUNEZ JJ, Trujillo-Santos J, Bertoletti L, Lobo JL, et al
    TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study.
    Thromb Res. 2022;213 Suppl 2:S37-S38.
    PubMed     Abstract available


  27. SALGADO M, Molina R, Vazquez EB, Martinez E, et al
    TEMPORARY REMOVAL: PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study.
    Thromb Res. 2022;213 Suppl 2:S36-S37.
    PubMed     Abstract available


  28. DONADINI MP, Squizzato A, Ferrazzi P, Maggioni S, et al
    TEMPORARY REMOVAL: PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study.
    Thromb Res. 2022;213 Suppl 2:S30-S31.
    PubMed     Abstract available


  29. ANIJS RJS, Chen Q, Lijfering WM, Cannegieter SC, et al
    TEMPORARY REMOVAL: OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis.
    Thromb Res. 2022;213 Suppl 2:S3.
    PubMed     Abstract available


  30. HAQUE F, Jawad N, Brzuszek A, Birk R, et al
    TEMPORARY REMOVAL: PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients.
    Thromb Res. 2022;213 Suppl 2:S28.
    PubMed     Abstract available


  31. FORESTA A, Colacioppo P, Baviera M, Ojeda-Fernandez L, et al
    TEMPORARY REMOVAL: PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
    Thromb Res. 2022;213 Suppl 2:S27-S28.
    PubMed     Abstract available


  32. DAGUENET E, Maison M, Tinquaut F, Giroux EA, et al
    TEMPORARY REMOVAL: PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study.
    Thromb Res. 2022;213 Suppl 2:S21.
    PubMed     Abstract available


  33. ALBERTSEN IE, Lyhne NM, Larsen TB, Nielsen PB, et al
    TEMPORARY REMOVAL: PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study.
    Thromb Res. 2022;213 Suppl 2:S21-S22.
    PubMed     Abstract available


  34. MORAN LO, Pesantez D, Vazquez EB, Garay DF, et al
    TEMPORARY REMOVAL: PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer.
    Thromb Res. 2022;213 Suppl 2:S20.
    PubMed     Abstract available


  35. GERVASO L, Laffi A, Meneses-Medina MI, Cella CA, et al
    TEMPORARY REMOVAL: PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms.
    Thromb Res. 2022;213 Suppl 2:S19-S20.
    PubMed     Abstract available


  36. JORGENSEN H, Horvath-Puho E, Laugesen K, Braekkan S, et al
    TEMPORARY REMOVAL: PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism.
    Thromb Res. 2022;213 Suppl 2:S18-S19.
    PubMed     Abstract available


  37. SILVA-CARDENAS DC, Pikabea-Diaz F, Zumarraga-Cuesta A, Lopez-Santillan M, et al
    TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients.
    Thromb Res. 2022;213 Suppl 2:S17.
    PubMed     Abstract available


  38. CHARLES S, Chaudier A, Fatrara T, Daguenet E, et al
    TEMPORARY REMOVAL: PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma.
    Thromb Res. 2022;213 Suppl 2:S13.
    PubMed     Abstract available


  39. TROELSEN FS, Vago EK, Horvath-Puho E, van Es N, et al
    TEMPORARY REMOVAL: PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study.
    Thromb Res. 2022;213 Suppl 2:S11.
    PubMed     Abstract available


  40. JAKOBSEN SS, Frokjaer JB, Fisker RV, Kristensen SR, et al
    TEMPORARY REMOVAL: PO-02: Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients.
    Thromb Res. 2022;213 Suppl 2:S11-S12.
    PubMed     Abstract available


  41. RUIZ M, Martin AM, Font C, Castellon V, et al
    TEMPORARY REMOVAL: OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study.
    Thromb Res. 2022;213 Suppl 2:S1.
    PubMed     Abstract available


    April 2022
  42. NOUMEGNI SR, Didier R, Mansourati V, Tromeur C, et al
    Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Thromb Res. 2022;214:93-105.
    PubMed     Abstract available


  43. LIND MM, Johansson M, Sjalander A, Johansson L, et al
    Incidence and risk factors of venous thromboembolism in men and women.
    Thromb Res. 2022;214:82-86.
    PubMed     Abstract available


  44. PORFIDIA A, Esposto G, Manzo C, Santini P, et al
    No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19.
    Thromb Res. 2022;214:44-46.
    PubMed    


  45. RUSSO F, Cianfanelli L, Chieffo A, Galli M, et al
    Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience.
    Thromb Res. 2022;214:40-43.
    PubMed    


  46. CATELLA J, Bertoletti L, Moustafa F, Nieto JA, et al
    Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
    Thromb Res. 2022;214:29-36.
    PubMed     Abstract available


    March 2022
  47. ROBERTS LN, Navaratnam AV, Arya R, Briggs TWR, et al
    Venous thromboembolism in patients hospitalised with COVID-19 in England.
    Thromb Res. 2022;213:138-144.
    PubMed     Abstract available


  48. VAN DER VLEUTEN CJM, Zwerink LGJM, Klappe EM, de Jong EMGJ, et al
    Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events?
    Thromb Res. 2022;213:30-33.
    PubMed    


  49. BOVA C, Vigna E, Gentile M, Pignataro FS, et al
    Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis.
    Thromb Res. 2022;213:43-46.
    PubMed    


  50. ABUFARHANEH M, Pandya RK, Alkhaja A, Iansavichene A, et al
    Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
    Thromb Res. 2022;213:47-56.
    PubMed     Abstract available


  51. PALARETI G, Bignamini AA, Urbanek T, Cini M, et al
    Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
    Thromb Res. 2022;211:140-146.
    PubMed     Abstract available


    February 2022
  52. ABRUZZO A, Gorantla V, Thomas SE
    Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review.
    Thromb Res. 2022;212:58-71.
    PubMed     Abstract available


  53. CATELLA J, Joly M, Pernod G
    Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
    Thromb Res. 2022;213:8.
    PubMed    


  54. VOCI D, Fedeli U, Farmakis IT, Hobohm L, et al
    Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.
    Thromb Res. 2022;212:44-50.
    PubMed     Abstract available


  55. DANIELSBACKA JS, Mannerkorpi K, Olsen MF
    Health care professionals' conceptions of respiratory symptoms and physical activity in patients with acute pulmonary embolism. A phenomenographic interview study.
    Thromb Res. 2022;212:22-29.
    PubMed     Abstract available


  56. BONNESEN K, Heide-Jorgensen U, Albertsen LW, Schmidt SAJ, et al
    Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism.
    Thromb Res. 2022;212:9-18.
    PubMed     Abstract available


  57. TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
    Advances in treatment of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2022;212:30-37.
    PubMed     Abstract available


  58. BEAUDOIN E, Kaka S, Gagnon E, Durivage A, et al
    Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study.
    Thromb Res. 2022;212:19-21.
    PubMed    


  59. BETENSKY M, Kumar R, Hankins JS, Goldenberg NA, et al
    Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
    Thromb Res. 2022;211:133-139.
    PubMed     Abstract available


  60. KALAITZOPOULOS DR, Panagopoulos A, Samant S, Ghalib N, et al
    Management of venous thromboembolism in pregnancy.
    Thromb Res. 2022;211:106-113.
    PubMed     Abstract available


    January 2022
  61. KALAYCI A, Gibson CM, Hernandez AF, Hull RD, et al
    Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
    Thromb Res. 2022;211:63-69.
    PubMed     Abstract available


  62. SHEN Y, Zhang Y, Xiong Y, Zhang Z, et al
    Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism.
    Thromb Res. 2022;211:49-55.
    PubMed     Abstract available


  63. POHL KR, Hobohm L, Krieg VJ, Sentler C, et al
    Impact of thyroid dysfunction on short-term outcomes and long-term mortality in patients with pulmonary embolism.
    Thromb Res. 2022;211:70-78.
    PubMed     Abstract available


  64. CABALLERO-ERASO C, Lopez-Ramirez C, Marin-Romero S, Carrera-Cueva C, et al
    Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study.
    Thromb Res. 2022;211:81-84.
    PubMed    


  65. BIKDELI B, Moustafa F, Nieto JA, Lee AI, et al
    Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.
    Thromb Res. 2022;211:10-18.
    PubMed     Abstract available


    December 2021
  66. PETRELLI F, Cabiddu M, Borgonovo K, Parati MC, et al
    Osimertinib-related venous thromboembolism in non small lung cancer.
    Thromb Res. 2021;210:63-66.
    PubMed    


  67. SIMARD C, Malhame I, Skeith L, Carson MP, et al
    Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice.
    Thromb Res. 2021;210:20-25.
    PubMed     Abstract available


  68. WANG L, Wei S, Zhou B, Wu S, et al
    Corrigendum to "A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors" [Thromb. Res. 202, June 2021, 52-58].
    Thromb Res. 2021;210:4-5.
    PubMed    


  69. SONNE-HOLM E, Kjaergaard J, Bang LE, Fosbol E, et al
    Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999-2018.
    Thromb Res. 2021;210:12-19.
    PubMed     Abstract available


  70. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
    Thromb Res. 2021;209:105.
    PubMed    


  71. ZUIN M, Engelen MM, Barco S, Spyropoulos AC, et al
    Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.
    Thromb Res. 2021;209:94-98.
    PubMed    


  72. DE WINTER MA, Timmers T, Hovens MMC, Iglesias Del Sol A, et al
    Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial.
    Thromb Res. 2021;209:86-93.
    PubMed     Abstract available


  73. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
    Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].
    Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545.
    PubMed    


    November 2021
  74. VERMA AA, Masoom H, Pou-Prom C, Shin S, et al
    Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients.
    Thromb Res. 2021;209:51-58.
    PubMed     Abstract available


  75. BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
    Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
    Thromb Res. 2021;208:190-197.
    PubMed     Abstract available


  76. ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
    Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
    Thromb Res. 2021;208:170-172.
    PubMed    


  77. GIRAUD M, Catella J, Cognet L, Helfer H, et al
    Management of acute venous thromboembolism in patients taking antiplatelet therapy.
    Thromb Res. 2021;208:156-161.
    PubMed     Abstract available


  78. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
    Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
    Thromb Res. 2021;208:106-111.
    PubMed     Abstract available


  79. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
    PubMed    


    October 2021
  80. LEE A, Oley F Jr, Lo M, Fong R, et al
    Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
    Thromb Res. 2021;208:148-155.
    PubMed     Abstract available


  81. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
    Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
    Thromb Res. 2021;208:79-82.
    PubMed     Abstract available


  82. HILL H, Robinson M, Lu L, Slaughter D, et al
    Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
    Thromb Res. 2021;208:71-78.
    PubMed     Abstract available


  83. HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
    Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Thromb Res. 2021;208:121-126.
    PubMed     Abstract available


  84. LI A, Brandt W, Brown C, Wang TF, et al
    Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
    Thromb Res. 2021;208:58-65.
    PubMed     Abstract available


  85. HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
    Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
    Thromb Res. 2021;208:52-57.
    PubMed     Abstract available


  86. LI J, Yi J, Hua L, Su Y, et al
    Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Thromb Res. 2021;208:45-51.
    PubMed     Abstract available


  87. BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
    Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
    Thromb Res. 2021;208:39-44.
    PubMed     Abstract available


  88. DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
    Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
    Thromb Res. 2021;208:4-10.
    PubMed     Abstract available


  89. PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
    Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
    Thromb Res. 2021;207:150-157.
    PubMed     Abstract available


  90. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
    Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
    Thromb Res. 2021;206:66-75.
    PubMed     Abstract available


    September 2021
  91. TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
    Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
    Thromb Res. 2021;207:143-149.
    PubMed     Abstract available


  92. LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
    Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
    Thromb Res. 2021;207:113-115.
    PubMed    


  93. MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
    Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
    Thromb Res. 2021;207:116-122.
    PubMed     Abstract available


  94. GABET A, Grave C, Tuppin P, Emmerich J, et al
    Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
    Thromb Res. 2021;207:67-74.
    PubMed     Abstract available


  95. OHASHI Y, Ikeda M, Kunitoh H, Sasako M, et al
    One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
    Thromb Res. 2021 Sep 21. pii: S0049-3848(21)00464.
    PubMed     Abstract available


  96. OAKES M, Arastu A, Kato C, Somers J, et al
    Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Thromb Res. 2021;207:96-98.
    PubMed     Abstract available


    August 2021
  97. STESSEL B, Peeters J, Bruckers L, Nulens M, et al
    Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
    Thromb Res. 2021;206:139-141.
    PubMed    


  98. HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
    Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
    Thromb Res. 2021;206:128-130.
    PubMed    


  99. YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
    Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
    Thromb Res. 2021;206:99-103.
    PubMed     Abstract available


  100. WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
    Pulmonary embolism and deep vein thrombosis: Similar but different.
    Thromb Res. 2021;206:88-98.
    PubMed     Abstract available


  101. JOHNSON SA, Jones AE, Young E, Jennings C, et al
    A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Thromb Res. 2021;206:120-127.
    PubMed     Abstract available


  102. FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
    Media portrayals of pulmonary embolism.
    Thromb Res. 2021;206:52-54.
    PubMed    


  103. FILIPPI L, Sartori M, Facci M, Trentin M, et al
    Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
    Thromb Res. 2021;206:29-32.
    PubMed     Abstract available


  104. HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
    Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
    Thromb Res. 2021;207:134-139.
    PubMed     Abstract available


  105. KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
    Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
    Thromb Res. 2021;204:114-122.
    PubMed     Abstract available


    July 2021
  106. HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
    Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
    Thromb Res. 2021;206:36-41.
    PubMed     Abstract available


  107. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
    Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
    Thromb Res. 2021;205:63-69.
    PubMed     Abstract available


  108. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
    "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
    Thromb Res. 2021;205:56-62.
    PubMed     Abstract available


  109. LACHANT D, Roto D, Rappaport S, Prasad P, et al
    Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
    Thromb Res. 2021;205:40-43.
    PubMed    


  110. METRA B, Summer R, Brooks SE, George G, et al
    Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
    Thromb Res. 2021;205:84-91.
    PubMed     Abstract available


  111. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
    Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
    Thromb Res. 2021;205:11-16.
    PubMed     Abstract available


  112. COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
    Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
    Thromb Res. 2021;206:1-4.
    PubMed    


  113. RIGATELLI G, Zuin M
    Not all patent foramen ovales are alike!
    Thromb Res. 2021;203:81.
    PubMed    


  114. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
    Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Thromb Res. 2021;205:17-23.
    PubMed     Abstract available


    June 2021
  115. JIN MC, Sussman ES, Feng AY, Han SS, et al
    Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
    Thromb Res. 2021;204:126-133.
    PubMed     Abstract available


  116. RIVERA-LEBRON B, Bauersachs R
    Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
    Thromb Res. 2021;204:101-107.
    PubMed     Abstract available


  117. KO D, Preis SR, Johnson AD, Vasan RS, et al
    Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
    Thromb Res. 2021;204:108-113.
    PubMed     Abstract available


  118. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
    S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
    Thromb Res. 2021;204:81-87.
    PubMed     Abstract available


  119. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
    Difference between Japanese and White patients with acute pulmonary embolism.
    Thromb Res. 2021;204:52-56.
    PubMed    


  120. BAN L, Abdul Sultan A, West J, Tata LJ, et al
    External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
    Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
    PubMed     Abstract available


  121. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
    Management of high-risk pulmonary embolism in pregnancy.
    Thromb Res. 2021;204:57-65.
    PubMed     Abstract available


  122. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
    Cancer risk after a venous thrombotic event - RIETE score.
    Thromb Res. 2021;202:43-44.
    PubMed    


  123. VALERIO L, Corsi G, Granziera S, Holm K, et al
    Sex differences in Lemierre syndrome: Individual patient-level analysis.
    Thromb Res. 2021;202:36-39.
    PubMed    


    May 2021
  124. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
    Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
    Thromb Res. 2021;204:9-12.
    PubMed     Abstract available


  125. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
    Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thromb Res. 2021;204:29-31.
    PubMed    


  126. LE MAO R, Tromeur C, Couturaud F
    A case of acute pulmonary embolism with severe haemoptysis.
    Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
    PubMed     Abstract available


  127. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
    Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Thromb Res. 2021;203:172-185.
    PubMed     Abstract available


  128. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
    The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
    Thromb Res. 2021;203:155-162.
    PubMed     Abstract available


  129. BARATH B, Bogati R, Miklos T, Kallai J, et al
    Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
    Thromb Res. 2021;203:110-116.
    PubMed     Abstract available


  130. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
    Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
    Thromb Res. 2021;203:93-100.
    PubMed     Abstract available


  131. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
    A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
    Thromb Res. 2021;203:190-195.
    PubMed     Abstract available


  132. MUMOLI N, Conte G, Cei M, Vitale J, et al
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Thromb Res. 2021;203:82-84.
    PubMed    


  133. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
    Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
    Thromb Res. 2021;203:74-80.
    PubMed     Abstract available


  134. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
    Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
    Thromb Res. 2021;201:18-22.
    PubMed     Abstract available


    April 2021
  135. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
    Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Thromb Res. 2021;202:155-161.
    PubMed     Abstract available


  136. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
    Pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2021;202:162-169.
    PubMed     Abstract available


  137. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
    Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
    Thromb Res. 2021;202:145-147.
    PubMed    


    March 2021
  138. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
    Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
    Thromb Res. 2021;202:128-133.
    PubMed     Abstract available


  139. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
    Lifestyle factors and venous thromboembolism in two cohort studies.
    Thromb Res. 2021;202:119-124.
    PubMed     Abstract available


  140. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
    Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
    Thromb Res. 2021;202:105-107.
    PubMed    


  141. SKEITH L, Le Gal G, Rodger MA
    Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Thromb Res. 2021;202:134-138.
    PubMed     Abstract available


  142. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
    COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
    Thromb Res. 2021;202:77-83.
    PubMed     Abstract available


  143. ALLEN S, Chan L, Masic D, Porcaro K, et al
    Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
    Thromb Res. 2021;202:96-99.
    PubMed    


  144. PETRELLI F, Solinas C
    Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
    PubMed    


  145. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
    Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Thromb Res. 2021;202:17-23.
    PubMed     Abstract available


  146. LACUT K, Le Moigne E, Couturaud F, Font C, et al
    Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
    Thromb Res. 2021;202:59-66.
    PubMed     Abstract available


  147. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
    A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Thromb Res. 2021;202:31-35.
    PubMed     Abstract available


  148. FRERE C, Ederhy S, Salem JE
    Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
    Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
    PubMed    


  149. WANG L, Wei S, Zhou B, Wu S, et al
    A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Thromb Res. 2021;202:52-58.
    PubMed     Abstract available


  150. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
    Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
    Thromb Res. 2021;199:143-148.
    PubMed     Abstract available


  151. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
    The effect of race on composite thrombotic events in patients with COVID-19.
    Thromb Res. 2021;199:10-13.
    PubMed     Abstract available


    February 2021
  152. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
    Three-month follow-up of pulmonary embolism in patients with COVID-19.
    Thromb Res. 2021;201:113-115.
    PubMed    


  153. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
    Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    Thromb Res. 2021;201:131-138.
    PubMed     Abstract available


  154. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
    Thromb Res. 2021;201:63-72.
    PubMed     Abstract available


  155. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
    Thromb Res. 2021;201:90-99.
    PubMed     Abstract available


  156. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
    Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
    Thromb Res. 2021;201:1-5.
    PubMed     Abstract available


  157. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
    An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
    Thromb Res. 2021;200:99-101.
    PubMed    



  158. Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
    Thromb Res. 2021;200:130-132.
    PubMed    


    January 2021
  159. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
    Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
    Thromb Res. 2021;200:48-50.
    PubMed    


  160. BECATTINI C, Cimini LA, Carrier M
    Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Thromb Res. 2021;200:41-47.
    PubMed     Abstract available


  161. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
    Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
    Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
    PubMed    


  162. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
    Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
    Thromb Res. 2021;199:101-105.
    PubMed     Abstract available


  163. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
    Venous-thromboembolism in elderly patients with acute myeloid leukemia.
    Thromb Res. 2021;200:9-11.
    PubMed    


  164. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
    Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
    Thromb Res. 2021;200:23-29.
    PubMed     Abstract available


  165. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
    Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    Thromb Res. 2021;199:85-96.
    PubMed     Abstract available


  166. MURGIER M, Fouillet L, Ollier E, Merah A, et al
    Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
    Thromb Res. 2021;199:106-109.
    PubMed    


  167. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
    Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
    Thromb Res. 2021;199:97-100.
    PubMed    


  168. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
    Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2021;199:123-131.
    PubMed     Abstract available


  169. MOIK F, Makatsariya A, Ay C
    Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Thromb Res. 2021;199:38-42.
    PubMed     Abstract available


  170. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
    In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
    Thromb Res. 2021;197:112-113.
    PubMed    


  171. PANCANI R, Villari L, Foci V, Parri G, et al
    Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Thromb Res. 2021;197:44-47.
    PubMed     Abstract available


    December 2020
  172. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
    Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
    Thromb Res. 2020;199:14-18.
    PubMed     Abstract available


  173. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
    Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Thromb Res. 2020;199:59-66.
    PubMed     Abstract available


  174. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
    Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Thromb Res. 2020;199:82-84.
    PubMed    


  175. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
    Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
    Thromb Res. 2020;199:32-34.
    PubMed    


  176. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
    Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
    Thromb Res. 2020;198:135-138.
    PubMed     Abstract available


  177. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
    Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
    Thromb Res. 2020;198:163-170.
    PubMed     Abstract available


  178. DE WIT K, Linkins LA
    A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
    Thromb Res. 2020;198:83-85.
    PubMed     Abstract available


  179. MIAO R, Dong X, Gong J, Wang Y, et al
    Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2020;198:122-131.
    PubMed     Abstract available


  180. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
    Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;198:103-114.
    PubMed     Abstract available


  181. WANG L, Chen F, Bai L, Yi Q, et al
    In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
    Thromb Res. 2020;196:541-542.
    PubMed    


  182. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
    COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Thromb Res. 2020;196:355-358.
    PubMed     Abstract available


    November 2020
  183. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
    Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
    Thromb Res. 2020;198:26-33.
    PubMed     Abstract available


  184. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
    Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
    Thromb Res. 2020;198:1-6.
    PubMed     Abstract available


  185. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
    Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
    Thromb Res. 2020;198:52-54.
    PubMed    


  186. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
    Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
    Thromb Res. 2020;198:34-39.
    PubMed     Abstract available


  187. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
    D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
    Thromb Res. 2020;197:160-164.
    PubMed     Abstract available


  188. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
    Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Thromb Res. 2020;197:144-152.
    PubMed     Abstract available


  189. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
    Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
    Thromb Res. 2020;197:94-99.
    PubMed     Abstract available


  190. ROBERGE G, Delluc A
    Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
    Thromb Res. 2020;197:77-83.
    PubMed     Abstract available


  191. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
    Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
    Thromb Res. 2020;197:48-55.
    PubMed     Abstract available


  192. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
    Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
    Thromb Res. 2020;197:8-12.
    PubMed     Abstract available


  193. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
    The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
    Thromb Res. 2020;195:228-230.
    PubMed    


  194. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
    Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
    Thromb Res. 2020;198:40-48.
    PubMed     Abstract available


    October 2020
  195. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
    Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
    Thromb Res. 2020;196:539-540.
    PubMed    


  196. SPEED V, Patel JP, Roberts LN, Patel RK, et al
    UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
    Thromb Res. 2020;197:16-19.
    PubMed    


  197. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
    The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
    Thromb Res. 2020;196:486-490.
    PubMed     Abstract available


  198. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
    PubMed    


  199. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
    Thromb Res. 2020;196:435-436.
    PubMed    


  200. HAN X, Li C, Zhang S, Hou X, et al
    Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
    Thromb Res. 2020;196:500-509.
    PubMed     Abstract available


  201. VALERIO L, Corsi G, Sebastian T, Barco S, et al
    Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
    Thromb Res. 2020;196:494-499.
    PubMed     Abstract available


  202. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
    Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
    Thromb Res. 2020;196:476-482.
    PubMed     Abstract available


  203. GERSTEIN L, Koolian M, Schwartz BC
    Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
    Thromb Res. 2020;196:463-465.
    PubMed    


  204. DOYLE AJ, Thomas W, Retter A, Besser M, et al
    Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
    Thromb Res. 2020;196:454-456.
    PubMed    


  205. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
    Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
    Thromb Res. 2020;196:444-453.
    PubMed     Abstract available


  206. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
    Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
    Thromb Res. 2020;194:220-221.
    PubMed    


    September 2020
  207. YANG M, Qi J, Tang Y, Wu D, et al
    Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;196:410-413.
    PubMed    


  208. MA SG, Hu J, Huang Y
    The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
    Thromb Res. 2020;196:325-334.
    PubMed     Abstract available


  209. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
    D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Thromb Res. 2020;196:318-321.
    PubMed    


  210. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
    High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Thromb Res. 2020;196:349-354.
    PubMed     Abstract available


  211. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
    Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Thromb Res. 2020;196:308-312.
    PubMed     Abstract available


  212. ROLVING N, Bloch-Nielsen JR, Brocki BC, Andreasen J, et al
    Perspectives of patients and health professionals on important factors influencing rehabilitation following acute pulmonary embolism: A multi-method study.
    Thromb Res. 2020;196:283-290.
    PubMed     Abstract available


  213. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
    Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Thromb Res. 2020;196:313-317.
    PubMed     Abstract available


  214. AGNELLI G, Hoffmann U, Hainaut P, Gaine S, et al
    ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
    Thromb Res. 2020;196:297-304.
    PubMed     Abstract available


  215. DELATE T, Charlu M, Zhu S, Pai A, et al
    Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
    Thromb Res. 2020;196:367-370.
    PubMed     Abstract available


  216. MIRO O, Llorens P, Aguirre A, Lozano L, et al
    Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
    Thromb Res. 2020;196:322-324.
    PubMed    


  217. PIZZI R, Gini G, Caiano L, Castelli B, et al
    Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Thromb Res. 2020;196:209-212.
    PubMed     Abstract available


  218. RAJENDRAM R, Kharal GA, Mahmood N, Kharal M, et al
    Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization.
    Thromb Res. 2020;196:206-208.
    PubMed     Abstract available


    August 2020
  219. HANNEVIK TL, Brekke J, Enden T, Froen H, et al
    Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.
    Thromb Res. 2020;196:238-244.
    PubMed     Abstract available


  220. BEENEN LFM, Bos LD, Scheerder MJ, Lobe NHJ, et al
    Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia.
    Thromb Res. 2020;196:135-137.
    PubMed    


  221. ZERMATTEN MG, Pantet O, Gomez F, Schneider A, et al
    Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
    Thromb Res. 2020;196:222-226.
    PubMed    


  222. SCHAEFER JK, Henke PK, Barnes GD
    Managing suspected venous thromboembolism when a pandemic limits diagnostic testing.
    Thromb Res. 2020;196:213-214.
    PubMed    


  223. COELHO J, Divernet-Queriaud M, Roy PM, Penaloza A, et al
    Comparison of the Wells score and the revised Geneva score as a tool to predict pulmonary embolism in outpatients over age 65.
    Thromb Res. 2020;196:120-126.
    PubMed     Abstract available


  224. JARVIS KB, Nielsen RL, Gupta R, Hede FD, et al
    Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
    Thromb Res. 2020;196:15-20.
    PubMed     Abstract available


  225. PORFIDIA A, Valeriani E, Pola R, Porreca E, et al
    Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.
    Thromb Res. 2020;196:67-74.
    PubMed     Abstract available


  226. KUNUTSOR SK, Laukkanen JA
    Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis.
    Thromb Res. 2020;196:27-30.
    PubMed    


  227. FRIBERG L, Svennberg E
    A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism.
    Thromb Res. 2020;195:238-242.
    PubMed     Abstract available


  228. NOJIMA J, Kaneshige R, Motoki Y, Ieko M, et al
    Increased oxidative stress may be a risk factor for thromboembolic complications in patients with antiphospholipid syndrome.
    Thromb Res. 2020;196:52-53.
    PubMed    


  229. TSOLAKI V, Zakynthinos GE, Mantzarlis K
    Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients.
    Thromb Res. 2020;196:25-26.
    PubMed    


    July 2020
  230. KOVACS MR, Lazo-Langner A, Louzada ML, Kovacs MJ, et al
    Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism.
    Thromb Res. 2020;195:231-232.
    PubMed    


  231. HASSAN S, Fanola C, Beckman A, Li F, et al
    Adult Langerhans histiocytosis with rare BRAF mutation complicated by massive pulmonary embolism.
    Thromb Res. 2020;193:207-210.
    PubMed    


  232. ALBERTSEN IE, Nielsen PB
    How to optimize the value of administrative venous thromboembolism codes.
    Thromb Res. 2020;194:195-196.
    PubMed    


  233. NITHIANANDAN H, Reilly A, Tritschler T, Wells P, et al
    Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2020;195:195-208.
    PubMed     Abstract available


  234. ZUIN M, Barco S, Zuliani G, Roncon L, et al
    Management of high-risk pulmonary embolism in an "unstable medical environment": Not only a matter of hemodynamic.
    Thromb Res. 2020;195:193-194.
    PubMed    


  235. TRIMAILLE A, Curtiaud A, Marchandot B, Matsushita K, et al
    Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Thromb Res. 2020;193:166-169.
    PubMed    


  236. PIAZZA G
    A fortune teller's dream or clinician's nightmare: Right ventricular assessment for risk prediction in pulmonary embolism.
    Thromb Res. 2020;195:169-170.
    PubMed    


  237. EICHINGER S, Lin M, Shi M, Grosso MA, et al
    Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
    Thromb Res. 2020;195:209-214.
    PubMed     Abstract available


  238. LECUMBERRI R, Ruiz-Artacho P, Trujillo-Santos J, Brenner B, et al
    Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia.
    Thromb Res. 2020;195:139-145.
    PubMed     Abstract available


  239. WHYTE MB, Kelly PA, Gonzalez E, Arya R, et al
    Pulmonary embolism in hospitalised patients with COVID-19.
    Thromb Res. 2020;195:95-99.
    PubMed     Abstract available


  240. GHANIMA W, Brodin E, Schultze A, Shepherd L, et al
    Incidence and prevalence of venous thromboembolism in Norway 2010-2017.
    Thromb Res. 2020;195:165-168.
    PubMed    


  241. ANDREW L, Ni Ainle F, Blondon M, Rodger MA, et al
    Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality.
    Thromb Res. 2020;193:190-197.
    PubMed     Abstract available


  242. PETERSEN PB, Jorgensen CC, Gromov K, Kehlet H, et al
    Venous thromboembolism after fast-track unicompartmental knee arthroplasty - A prospective multicentre cohort study of 3927 procedures.
    Thromb Res. 2020;195:81-86.
    PubMed     Abstract available


  243. SCHWAB-DAUGHERTY EM, Peng MR, Caraccio EE, Stevens SM, et al
    Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism.
    Thromb Res. 2020;195:58-61.
    PubMed    


  244. YURIDITSKY E, Mitchell OJL, Sista AK, Xia Y, et al
    Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism.
    Thromb Res. 2020;195:29-34.
    PubMed     Abstract available


  245. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
    Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
    Thromb Res. 2020;191:148-150.
    PubMed     Abstract available


  246. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
    Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
    Thromb Res. 2020;191:145-147.
    PubMed     Abstract available


  247. MARAVEYAS A
    Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.
    Thromb Res. 2020;191 Suppl 1:S91-S98.
    PubMed     Abstract available


  248. SANFILIPPO KM
    Assessing the risk of venous thromboembolism in multiple myeloma.
    Thromb Res. 2020;191 Suppl 1:S74-S78.
    PubMed     Abstract available


  249. GEROTZIAFAS GT, Mahe I, Lefkou E, AboElnazar E, et al
    Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
    Thromb Res. 2020;191 Suppl 1:S50-S57.
    PubMed     Abstract available


  250. ILICH A, Kumar V, Henderson M, Mallick R, et al
    Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study.
    Thromb Res. 2020;191 Suppl 1:S31-S36.
    PubMed     Abstract available


  251. NOBLE S
    Venous thromboembolism in palliative care patients: what do we know?
    Thromb Res. 2020;191 Suppl 1:S128-S132.
    PubMed     Abstract available


  252. VERSO M, Agnelli G
    Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life.
    Thromb Res. 2020;191 Suppl 1:S123-S127.
    PubMed     Abstract available


    June 2020
  253. PREVITALI G, Seghezzi M, Moioli V, Sonzogni A, et al
    The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
    Thromb Res. 2020;194:192-194.
    PubMed    


  254. NICHETTI F, Russo GL, Prelaj A, Provenzano L, et al
    ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
    Thromb Res. 2020;194:176-177.
    PubMed    


  255. ZHANG GC, Zhang YY, Zeng QZ, Meng XY, et al
    Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.
    Thromb Res. 2020;194:168-175.
    PubMed     Abstract available


  256. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism.
    Thromb Res. 2020;193:160-165.
    PubMed     Abstract available


  257. ROBIN P, van Es N, Le Roux PY, Rondina M, et al
    Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis.
    Thromb Res. 2020;194:153-157.
    PubMed     Abstract available


  258. MAKHOUL T, Kelly G, Kersten B, Nadler M, et al
    Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal.
    Thromb Res. 2020;194:158-164.
    PubMed     Abstract available


  259. OVERSTAD S, Tjonnfjord E, Garabet L, Fronas S, et al
    Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
    Thromb Res. 2020;194:116-118.
    PubMed    


  260. HAYKAL T, Zayed Y, Deliwala S, Kerbage J, et al
    Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
    Thromb Res. 2020;194:57-65.
    PubMed     Abstract available


  261. DEL-TORO-CERVERA J, Demelo-Rodriguez P, Galeano-Valle F, Fidalgo A, et al
    Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry.
    Thromb Res. 2020;194:178-182.
    PubMed     Abstract available


  262. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?
    Thromb Res. 2020;193:86-89.
    PubMed     Abstract available


  263. MURTHY SK, Robertson McCurdy AB, Carrier M, McCurdy JD, et al
    Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting.
    Thromb Res. 2020;194:26-32.
    PubMed     Abstract available


  264. PICART G, Robin P, Tromeur C, Orione C, et al
    Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Thromb Res. 2020;194:1-7.
    PubMed     Abstract available


  265. IBRAHIM-KOSTA M, Bailly P, Silvy M, Saut N, et al
    ABO blood group, glycosyltransferase activity and risk of venous thromboembolism.
    Thromb Res. 2020;193:31-35.
    PubMed     Abstract available


  266. VELASCO D, Jimenez D, Bikdeli B, Muriel A, et al
    Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders.
    Thromb Res. 2020;193:90-97.
    PubMed     Abstract available


    May 2020
  267. HENDRIKS SV, Bavalia R, van Bemmel T, Bistervels IM, et al
    Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study.
    Thromb Res. 2020;193:60-65.
    PubMed     Abstract available


  268. DESBOROUGH MJR, Doyle AJ, Griffiths A, Retter A, et al
    Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
    Thromb Res. 2020;193:1-4.
    PubMed    


  269. PACKARD A, Delate T, Martinez K, Clark NP, et al
    Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service.
    Thromb Res. 2020;193:40-44.
    PubMed     Abstract available


  270. CHEN X, Shao X, Zhang Y, Zhang Z, et al
    Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2020;193:99-106.
    PubMed     Abstract available


  271. KONIECZYNSKA M, Kupis RW, Bijak P, Malinowski KP, et al
    Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy matters.
    Thromb Res. 2020;193:116-121.
    PubMed     Abstract available


  272. AKEL T, Qaqa F, Abuarqoub A, Shamoon F, et al
    Pulmonary embolism: A complication of COVID 19 infection.
    Thromb Res. 2020;193:79-82.
    PubMed     Abstract available


  273. PARRY AH, Wani AH
    Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management.
    Thromb Res. 2020 May 16. pii: S0049-3848(20)30194.
    PubMed    


  274. GALEANO-VALLE F, Oblitas CM, Ferreiro-Mazon MM, Alonso-Munoz J, et al
    Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
    Thromb Res. 2020 May 15. pii: S0049-3848(20)30189.
    PubMed     Abstract available


  275. RAHMANI J, Haghighian Roudsari A, Bawadi H, Thompson J, et al
    Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants.
    Thromb Res. 2020;192:64-72.
    PubMed     Abstract available


  276. ROSEN RJ
    Early thromboembolic events in hospitalized COVID-19 patients.
    Thromb Res. 2020;192:1.
    PubMed    


  277. VITALI C, Minniti A, Caporali R, Del Papa N, et al
    Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19.
    Thromb Res. 2020;192:21-22.
    PubMed    


  278. NISHIMOTO Y, Yamashita Y, Morimoto T, Saga S, et al
    Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
    Thromb Res. 2020;191:66-75.
    PubMed     Abstract available


  279. BRUGGEMANN R, Gietema H, Jallah B, Ten Cate H, et al
    Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
    Thromb Res. 2020 May 1. pii: S0049-3848(20)30163.
    PubMed    


    April 2020
  280. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
    Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
    Thromb Res. 2020;191:103-112.
    PubMed     Abstract available


  281. LODIGIANI C, Iapichino G, Carenzo L, Cecconi M, et al
    Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Thromb Res. 2020;191:9-14.
    PubMed     Abstract available


  282. ELLIS-KAHANA J, Sparks AD, Gimovsky AC, James AH, et al
    Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.
    Thromb Res. 2020;191:42-49.
    PubMed     Abstract available


  283. JOHNSEN HS, Bjori E, Hindberg K, Braekkan SK, et al
    Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
    Thromb Res. 2020;191:82-89.
    PubMed     Abstract available


  284. RONCON L, Zuin M, Zonzin P
    Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.
    Thromb Res. 2020;190:102.
    PubMed    


  285. MARTINELLI I, Ferrazzi E, Ciavarella A, Erra R, et al
    Pulmonary embolism in a young pregnant woman with COVID-19.
    Thromb Res. 2020;191:36-37.
    PubMed    


  286. FANG Q, Du W, Zhang X, Chen D, et al
    Venous thromboembolism and postoperative bleeding in thyroid surgery patients.
    Thromb Res. 2020;190:99-101.
    PubMed    


  287. ROTZINGER DC, Beigelman-Aubry C, von Garnier C, Qanadli SD, et al
    Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.
    Thromb Res. 2020;190:58-59.
    PubMed     Abstract available


    March 2020
  288. BOON GJAM, Barco S, Bertoletti L, Ghanima W, et al
    Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale.
    Thromb Res. 2020;190:45-51.
    PubMed     Abstract available


  289. KELLER K, Hobohm L, Barco S, Schmidtmann I, et al
    Venous thromboembolism in patients hospitalized for hip joint replacement surgery.
    Thromb Res. 2020;190:1-7.
    PubMed     Abstract available


  290. CHOI SH, Cha SI, Park JE, Park S, et al
    Electrocardiographic changes as a prognostic tool for hospitalized patients with pulmonary embolism.
    Thromb Res. 2020;192:61-63.
    PubMed    


  291. RENZI M, Stafoggia M, Michelozzi P, Davoli M, et al
    Short-term exposure to PM2.5 and risk of venous thromboembolism: A case-crossover study.
    Thromb Res. 2020;190:52-57.
    PubMed     Abstract available


  292. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
    Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
    Thromb Res. 2020 Mar 6. pii: S0049-3848(20)30069.
    PubMed    


  293. HASAN RA, Koh AY, Zia A
    The gut microbiome and thromboembolism.
    Thromb Res. 2020;189:77-87.
    PubMed     Abstract available


  294. BAUMGARTNER C, Go AS, Fan D, Sung SH, et al
    Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.
    Thromb Res. 2020;189:112-118.
    PubMed     Abstract available


  295. LIANG S, Tang W, Ye S, Xiang L, et al
    Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
    Thromb Res. 2020;190:129-134.
    PubMed     Abstract available


    February 2020
  296. DEGUCHI TK, Deguchi H, Guo Z, Elias DJ, et al
    Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.
    Thromb Res. 2020;189:88-92.
    PubMed     Abstract available


  297. KUNUTSOR SK, Barrett MC, Whitehouse MR, Blom AW, et al
    Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: Meta-analyses of incidence, temporal trends and potential risk factors.
    Thromb Res. 2020;189:13-23.
    PubMed     Abstract available


  298. BAVIERA M, Barcella L, Vannini T, Colacioppo P, et al
    Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
    Thromb Res. 2020;188:97-99.
    PubMed    


  299. DANIELSBACKA JS, Hansson PO, Mannerkorpi K, Olsen MF, et al
    Physical activity and respiratory symptoms after pulmonary embolism. A longitudinal observational study.
    Thromb Res. 2020;189:55-60.
    PubMed     Abstract available


  300. FULCHER J, Carrier M
    Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia - time to reconsider current approaches?
    Thromb Res. 2020;188:100-102.
    PubMed     Abstract available


  301. SCHMIDT RA, Al Zaki A, Desilet N, Szefer E, et al
    Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.
    Thromb Res. 2020;188:106-114.
    PubMed     Abstract available


    January 2020
  302. ROBIN P, Grewal RK, Le Roux PY, Le Gal G, et al
    Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism.
    Thromb Res. 2020;188:25-27.
    PubMed    


  303. VAN ES J, Cheung YW, van Es N, Klok FA, et al
    Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
    Thromb Res. 2020;187:125-130.
    PubMed     Abstract available


  304. CALAIS C, Mercier G, Meusy A, Le Collen L, et al
    Pulmonary embolism home treatment: What GP want?
    Thromb Res. 2020;187:180-185.
    PubMed     Abstract available


  305. QUAN S, Smith J, Wu C, Koshman SL, et al
    Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism.
    Thromb Res. 2020;187:56-62.
    PubMed     Abstract available


  306. TSUYUKI Y, Yamashita Y, Morimoto T, Amano H, et al
    Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE Registry.
    Thromb Res. 2020;187:39-47.
    PubMed     Abstract available


  307. GARVEY S, Dudzinski DM, Giordano N, Torrey J, et al
    Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes.
    Thromb Res. 2020;187:139-147.
    PubMed     Abstract available


    December 2019
  308. BIKDELI B, Wang Y, Jimenez D, Ross JS, et al
    Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism.
    Thromb Res. 2019;186:78-79.
    PubMed    


  309. DOU F, Zhang Y, Yi J, Zhu M, et al
    Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.
    Thromb Res. 2019;186:36-41.
    PubMed     Abstract available


  310. DZIKOWSKA-DIDUCH O, Kostrubiec M, Kurnicka K, Lichodziejewska B, et al
    "The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism".
    Thromb Res. 2019;186:30-35.
    PubMed     Abstract available


  311. FRENETTE A, Gershkovich B, Castellucci LA, Patel RV, et al
    Venous thromboembolism prophylaxis in obese, critically-ill patients: A survey of Ottawa region Intensivists.
    Thromb Res. 2019;186:42-44.
    PubMed    


    November 2019
  312. MEDEIROS SK, Emery B, Bhagirath V, Parpia S, et al
    Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
    Thromb Res. 2019;186:13-19.
    PubMed     Abstract available


  313. CANTOR N, Carrier M, Rodger MA, Veillet-Lemay G, et al
    Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study.
    Thromb Res. 2019;185:132-134.
    PubMed    


  314. GARIANI K, Hugon-Rodin J, Philippe J, Righini M, et al
    Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2019;185:102-108.
    PubMed     Abstract available


  315. BIKDELI B, Carrier MA, Bates SM
    Subsegmental pulmonary embolism: May not be a killer but indicates significant risk.
    Thromb Res. 2019 Nov 19. pii: S0049-3848(19)30504.
    PubMed    


  316. TRUGILHO IA, Renni MJP, Medeiros GC, Thuler LCS, et al
    Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
    Thromb Res. 2019;185:49-54.
    PubMed     Abstract available


  317. SIMONA A, Limacher A, Mean M, Golaz O, et al
    High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism.
    Thromb Res. 2019;185:5-12.
    PubMed     Abstract available


  318. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
    Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
    Thromb Res. 2019;185:13-19.
    PubMed     Abstract available


  319. JARVIS KB, LeBlanc M, Tulstrup M, Nielsen RL, et al
    Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
    Thromb Res. 2019;184:92-98.
    PubMed     Abstract available


  320. SKAJAA N, Szepligeti SK, Horvath-Puho E, Ghanima W, et al
    Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.
    Thromb Res. 2019;184:99-104.
    PubMed     Abstract available


  321. HENDRIKS SV, Huisman MV, Eikenboom JCJ, Fogteloo J, et al
    Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice.
    Thromb Res. 2019;184:122-128.
    PubMed     Abstract available


  322. YAMASHITA Y, Murata K, Morimoto T, Amano H, et al
    Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.
    Thromb Res. 2019;184:50-57.
    PubMed     Abstract available


    October 2019
  323. KRIEG VJ, Hobohm L, Liebetrau C, Guth S, et al
    Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.
    Thromb Res. 2019;185:20-26.
    PubMed     Abstract available


  324. BONNEFOY PB, Margelidon-Cozzolino V, Catella-Chatron J, Ayoub E, et al
    What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
    Thromb Res. 2019;184:67-76.
    PubMed     Abstract available


  325. STOLLER N, Limacher A, Mean M, Baumgartner C, et al
    Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism.
    Thromb Res. 2019;184:24-30.
    PubMed     Abstract available


  326. HEENKENDA MK, Malmstrom A, Lysiak M, Mudaisi M, et al
    Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
    Thromb Res. 2019;183:136-142.
    PubMed     Abstract available


  327. DE WINTER MA, Remme GCP, Kaasjager KHAH, Nijkeuter M, et al
    Short-term versus extended anticoagulant treatment for unprovoked venous thromboembolism: A survey on guideline adherence and physicians' considerations.
    Thromb Res. 2019;183:49-55.
    PubMed     Abstract available


  328. YU J, Li A, Laureano M, Crowther M, et al
    Frequency of arterial thromboembolism in populations with malignancies: A systematic review.
    Thromb Res. 2019;184:16-23.
    PubMed     Abstract available


  329. BYUN JM, Hong J, Yoon SS, Koh Y, et al
    Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
    Thromb Res. 2019;183:131-135.
    PubMed     Abstract available


    August 2019
  330. RAJPURKAR M, Williams S, Goldenberg NA, Van Ommen CH, et al
    Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children.
    Thromb Res. 2019;183:98-105.
    PubMed     Abstract available


    May 2019
  331. GILLESPIE C, Foley S, Rowan M, Ewins K, et al
    The OPTICA study (Optimised Computed Tomography Pulmonary Angiography in Pregnancy Quality and Safety study): Rationale and design of a prospective trial assessing the quality and safety of an optimised CTPA protocol in pregnancy.
    Thromb Res. 2019;177:172-179.
    PubMed     Abstract available


  332. YAMASHITA Y, Morimoto T, Amano H, Takase T, et al
    Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
    Thromb Res. 2019;177:1-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: